Healthcare software provider Health Catalyst (NASDAQ:HCAT) will be reporting results this Thursday after market hours. Here’s what you need to know.
Health Catalyst met analysts’ revenue expectations last quarter, reporting revenues of $79.41 million, up 6.3% year on year. It was a satisfactory quarter for the company, with an impressive beat of analysts’ EBITDA estimates.
Is Health Catalyst a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting Health Catalyst’s revenue to grow 6.2% year on year to $80.57 million, improving from the 3.7% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.04 per share.
The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Health Catalyst has missed Wall Street’s revenue estimates twice over the last two years.
Looking at Health Catalyst’s peers in the data and analytics software segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Palantir delivered year-on-year revenue growth of 48%, beating analysts’ expectations by 6.8%, and MicroStrategy reported revenues up 2.7%, topping estimates by 1.2%. Palantir traded up 7.8% following the results while MicroStrategy was down 8.7%.
Read our full analysis of Palantir’s results here and MicroStrategy’s results here.
Questions about potential tariffs and corporate tax changes have caused much volatility in 2025. While some of the data and analytics software stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 3.4% on average over the last month. Health Catalyst is down 3.3% during the same time and is heading into earnings with an average analyst price target of $6.89 (compared to the current share price of $3.82).
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.